Insights

New Key Personnel Xeris Pharmaceuticals recently hired a new SVP of Global Development and Medical Affairs, Dr. Anh Nguyen. This presents an opportunity for sales teams to establish connections with the new leadership and potentially offer tailored solutions to support the company's growth strategies.

Product Development Collaboration Xeris Pharmaceuticals is collaborating with Beta Bionics to develop a glucagon product for proprietary pump technology and a dual-hormone pump for diabetes. Sales teams can explore partnership opportunities to provide complementary products or services that enhance these innovative solutions.

Industry Event Participation Xeris Pharmaceuticals has been actively participating in industry events like the Piper Sandler Annual Healthcare Conference. Sales representatives can leverage these events to engage with key decision-makers, showcase their offerings, and build rapport with industry influencers.

Financial Health & Growth With a revenue range of $50M - 100M and recent funding of $200M, Xeris Pharmaceuticals demonstrates financial stability and potential for expansion. Sales professionals can target the company for partnership opportunities, knowing they have the resources to invest in new solutions.

Competitive Landscape Analysis By understanding Xeris' competitors like MannKind Corporation, Insulet Corporation, and larger pharmaceutical companies such as Sanofi, Johnson & Johnson, AstraZeneca, and Eli Lilly, sales teams can position their offerings effectively by highlighting unique value propositions and differentiation strategies.

Xeris Pharmaceuticals, Inc. Tech Stack

Xeris Pharmaceuticals, Inc. uses 8 technology products and services including Open Graph, Recognize, LinkedIn, and more. Explore Xeris Pharmaceuticals, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Recognize
    Human Capital Management
  • LinkedIn
    Online Community Software
  • Akamai Bot Manager
    Security
  • Adobe Tag Manager
    Tag Management
  • SAP Concur
    Travel And Expense Management
  • Microsoft IIS
    Web Servers
  • Facebook
    Widgets

Media & News

Xeris Pharmaceuticals, Inc.'s Email Address Formats

Xeris Pharmaceuticals, Inc. uses at least 1 format(s):
Xeris Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@xerispharma.comJDoe@xerispharma.com
96%
Last@xerispharma.comDoe@xerispharma.com
2%
FMiddleLast@xerispharma.comJMichaelDoe@xerispharma.com
1%
FirstL@xerispharma.comJohnD@xerispharma.com
1%

Frequently Asked Questions

Where is Xeris Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s main headquarters is located at 1375 W Fulton St Suite 1300 Chicago, Illinois 60607 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Xeris Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Xeris Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xeris Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is XERS.

What is Xeris Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s official website is xerispharma.com and has social profiles on LinkedIn.

How much revenue does Xeris Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of January 2025, Xeris Pharmaceuticals, Inc.'s annual revenue reached $75M.

What is Xeris Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Xeris Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of January 2025, Xeris Pharmaceuticals, Inc. has approximately 392 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Legal Officer & Corporate Secretary: B. H.Chief Financial Officer: S. P.Vice President Of Product Development And Cmc-R&d: J. T.. Explore Xeris Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Xeris Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Xeris Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s tech stack includes Open GraphRecognizeLinkedInAkamai Bot ManagerAdobe Tag ManagerSAP ConcurMicrosoft IISFacebook.

What is Xeris Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more Xeris Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Xeris Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of January 2025, Xeris Pharmaceuticals, Inc. has raised $200M in funding. The last funding round occurred on Mar 06, 2024 for $200M.

When was Xeris Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. was founded in 2005.
Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, Inc.

Pharmaceutical ManufacturingIllinois, United States201-500 Employees

We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.

Section iconCompany Overview

Headquarters
1375 W Fulton St Suite 1300 Chicago, Illinois 60607 US
Phone number
Stock Symbol
XERS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
201-500

Section iconFunding & Financials

  • $200M

    Xeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.

  • $50M$100M

    Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Xeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.

  • $50M$100M

    Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.